Skip to main content
. 2024 Mar 15;166(1):138. doi: 10.1007/s00701-024-06025-x

Table 5.

Table summarising literature evaluating the survival benefit conferred by repeat resection for recurrent glioblastoma

Study Study design Total number of patients Number of resections Number of patients Median survival (months) Notes
Azoulay et al. [2] Retrospective 136 1 68 5.3
2 68 9.6
Chaichana et al. [22] Retrospective 578 1 354 6.8 Risk of infections or iatrogenic deficits did not increase with repeat resections (p > 0.05)
2 121 15.5
3 41 22.4
4 15 26.6
Delgado-Fernandez et al. [9] Retrospective 121 1 90 / The reoperation group had a median increase survival of 6.4 months compared with the non-reoperation group (p < 0.001)
2 31 /
Djamel-Eddine et al. [11] Retrospective 132 1 68 11
2 53 16
3 11 18
Filippini et al. [13] Retrospective 676 1 503 / Multivariable analysis showed no effect of reoperation on survival, whether performed within 9 months of the first surgery (HR 0.86, p 5 0.256) or after 9 months (HR 0.98; p 5 0.860)
2 173 /
Goldman et al. [14] Retrospective 163 1 74 / When timing of repeat resection was ignored, repeat resection was associated with a lower risk of death (HR 0.62, p = 0.01). However, when timing was taken into account, repeat resection was associated with a higher risk of death (HR 2.19, p < 0.001)
2 89 /
Mukherjee et al. [28] Prospective 312 1 167 6.9 Complication rates were 5.5% and 6.2% following repeat resection and primary resection, respectively (p > 0.05)
2 145 10.8
Nava et al. [23] Prospective 764 1 368 / HR for death after recurrence—1.05 (0.71–1.54) with reoperation vs conservative management
2 138 /
Ortega et al. [24] Retrospective 202 1 83 21.1 After adjusting for age, multiple resections were not an independent predictor of survival
2 94 25.5
3 25 29.0
Ringel et al. [15] Retrospective 503 1 82 22.7
2 421 29.3
3 72 34.3
4 9 26.4
Sastry et al. [30] Retrospective 368 1 291 7.0
2 77 12.8
Suchorska et al. [32] Prospective 105 1 34 / Post-recurrence survival (PRS) was 11.4 months (95% CI: 8.4–12.3) in patients who underwent surgery versus 9.8 months (95% CI: 6.6–15.1) in patients who did not undergo surgery (P 0.633)
2 71 /
Tugcu et al. [33] Retrospective 50 1 39 6.9
2 11 9.6
Tully et al. [34] Retrospective 204 1 105 9.0
2 49 20.1
Woernle et al. [37] Retrospective 98 1 58 14.8
2 40 18.8
Wann et al. [36] Retrospective 120 1 60 14
2 60 22